Gronghui, November 25-November 24, 2021, 01302.HK announced that the independently developed Yuranos abdominal aortic covered stent system (hereinafter referred to as "Yuranos capsule" or "product") has been registered and approved by the State Drug Administration (NMPA). This product is used for endovascular treatment of infrarenal abdominal aortic aneurysms and will provide a better instrument solution for patients with abdominal aortic aneurysms, especially those with complex aneurysms.
先健科技(01302.HK)新一代腹主动脉覆膜支架系统获批上市
The new generation of abdominal aorta covered stent system of 01302.HK has been approved to be listed on the market.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.